Shinichi Imafuku
Fukuoka University(JP)Fukuoka University Hospital(JP)Teikyo University(JP)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Cancer and Skin Lesions, Herpesvirus Infections and Treatments
Most-Cited Works
- → Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial(2022)325 cited
- → Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52‐week analysis from phase III open‐label multicenter Japanese study(2016)186 cited
- → Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis(2023)125 cited
- → A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis(2018)117 cited
- → Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double‐blind, phase 3 study(2016)84 cited
- → Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients